The degree of spasticity was assessed using the Modified Ashworth Scale (MAS) 7 which included the following scores: 0 (zero), no increase in muscle tone; 1 (one) slight increase in tone, manifested ...

[31] Bakheit (2000) To define an effective and safe dose of Dysport for the treatment of upper limb spasticity in stroke patients All had biceps, FDS, FDP, FCU, FCR MAS, range of movement ...

Usual care may vary across participants, potentially limiting the comparability of the two groups. Though widely accepted and used, the validity of the Modified Ashworth Scale to measure spasticity ...

Subscapularis spasticity was assessed by the change in passive shoulder lateral rotation and abduction. Upper limb spasticity was assessed using the Modified Ashworth Scale for shoulder medial ...

The MAS inter-rater reliability (PT1 VS PT2) for the hand spasticity assessment reported a moderate-substantial weighted kappa of 0.586, and an ICC of 0.911. According to Hager (2003) , ICC scores ...

Further screening of these full-text articles revealed that 94 articles used previous clinical scales such as MAS, MTS, or MMAS for spasticity assessment. Moreover, 57 articles presented concepts or ...

Treatment with the cannabis oral spray nabiximols helped to relieve spasticity — increased muscle stiffness and spasms common in people with multiple sclerosis (MS) — among participants in two ...

Following different Modified Ashworth Scale (MAS) levels, muscle resistance can occur at varying degrees through the ROM. The simulated spasticity of MAS 1+, based on the developed model, shows a ...

934; P <.001), as published in Multiple Sclerosis and Related Disorders. “Patients’ self-reported NRS score had a good correlation with clinician-evaluated MAS score for spasticity assessment in NMOSD ...

But when you have spasticity, which causes tight muscles and uncontrollable contractions, your pain is more than a temporary annoyance. Spasticity happens when all of your muscles contract at once ...

Both studies used similar designs: after a lead-in phase, patients who responded to the treatment were randomized to either Sativex or a placebo for 12 weeks, and spasticity in various muscles was ...